Skip to Main Content

Author Details

Andrew M Lowy
University of California San Diego
1985
220
63
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38051586The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids.JCI Insight2024
36305990Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?Ann Surg Oncol2023
37721516Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project.Cancer Res Commun2023
37489987Pancreatic Cyst Surveillance: Who, Why, How?Radiology2023
37802055Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancer.Cancer Cell2023
37673892A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer.Nat Commun2023
37292766A pancreatic cancer mouse model with human immunity.bioRxiv2023
37292693Tumor-resident regulatory T cells in pancreatic cancer express the αvβ5 integrin as a targetable activation marker.bioRxiv2023
37378556Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma.Cancer Res2023
37306759Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma.Cancer Res2023
37034696Pancreatic Ductal Adenocarcinoma Induces Neural Injury that Promotes a Transcriptomic and Functional Repair Signature by Peripheral Neuroglia.Res Sq2023
37433986Pancreatic ductal adenocarcinoma induces neural injury that promotes a transcriptomic and functional repair signature by peripheral neuroglia.Oncogene2023
36882540Publisher Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome.Nature2023
36477643Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis.Surg Endosc2023
36646789Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation.Nat Cell Biol2023
36369408ASO Visual Abstract: Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC?Ann Surg Oncol2023
34972700Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.In Vivo2022
35603292Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test.Commun Med (Lond)2022
35454943The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies.Cancers (Basel)2022
36970055A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas.Cancer Res Commun2022
36571414Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens.J Vis Exp2022
36102565Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled Trial.J Am Coll Surg2022
36067351An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape.Clin Cancer Res2022
36198801Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome.Nature2022
34916338Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies.Gut Liver2022
33415564A Multi-institutional Study of Peritoneal Recurrence Following Resection of Low-grade Appendiceal Mucinous Neoplasms.Ann Surg Oncol2021
33603171Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.Oncogene2021
33653692Macropinocytosis in Cancer-Associated Fibroblasts Is Dependent on CaMKK2/ARHGEF2 Signaling and Functions to Support Tumor and Stromal Cell Fitness.Cancer Discov2021
33571625Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer.Int J Radiat Oncol Biol Phys2021
33905776Ki67 does not predict recurrence for low-grade appendiceal mucinous neoplasms with peritoneal dissemination after cytoreductive surgery and HIPEC.Hum Pathol2021
33740421Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis.Cancer Cell2021
33739856Clinical Data Prediction Model to Identify Patients With Early-Stage Pancreatic Cancer.JCO Clin Cancer Inform2021
33735448Predictors and significance of histologic response to neoadjuvant therapy for gastric cancer.J Surg Oncol2021
33565809Neoadjuvant Checkpoint Blockade in Lynch Syndrome-Related Pancreatic Adenocarcinoma.Pancreas2021
33845462Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2021
33750829Tumor-penetrating therapy for β5 integrin-rich pancreas cancer.Nat Commun2021
34994628Palbociclib as a Novel Therapy for Low-Grade Mucinous Carcinomatosis Peritonei of Appendiceal Origin.JCO Precis Oncol2021
34552012Targeting the IGF-Axis Potentiates Immunotherapy for Pancreatic Ductal Adenocarcinoma Liver Metastases by Altering the Immunosuppressive Microenvironment.Mol Cancer Ther2021
34638476Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond.Cancers (Basel)2021
34580114Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513.Clin Cancer Res2021
34625409Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.Cancer Prev Res (Phila)2021
34848876Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.Nature2021
34479480Tri-modal management of primary small cell carcinoma of the pancreas (SCCP): a rare neuroendocrine carcinoma (NEC).BMC Gastroenterol2021
33451980A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer.Clin Cancer Res2021
33475684Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial.JAMA Oncol2021
31597712Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability.Mol Cancer Ther2020
31745679Adherence with operative standards in the treatment of gastric cancer in the United States.Gastric Cancer2020
31985516Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.Am J Clin Oncol2020
32009658Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models.J Vis Exp2020
33270763Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.PLoS One2020
  • 1 - 50 of 220

Recommended Authors

Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 2015
Number of shared co-authors 1
University of Colorado
Career Start Year 2014
Number of shared co-authors 3
Stanford University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 2014
Number of shared co-authors 0
Houston Methodist Hospital
Career Start Year 2012
Number of shared co-authors 2
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Cancer Center Amsterdam
Career Start Year 2001
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
Weill Cornell University
Career Start Year 2000
Number of shared co-authors 7
Dana-Farber Cancer Institute
Career Start Year 1999
Number of shared co-authors 8
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 1
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 10
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1997
Number of shared co-authors 4
Hospital HM Universitario Sanchinarro
Career Start Year 1997
Number of shared co-authors 1
University of Toronto
Career Start Year 1996
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 2
National Defense Medical College
Career Start Year 1993
Number of shared co-authors 0
Georgetown University
Career Start Year 1993
Number of shared co-authors 2
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 0
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 2
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 6
University of Colorado School of Medicine
Career Start Year 1989
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 4
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 6
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Career Start Year 1983
Number of shared co-authors 11
Leiden University Medical Center: Leids Universitair Medisch Centrum.
Career Start Year 1977
Number of shared co-authors 3

Collaborators

University of California
Co-authored papers 30
University of Cincinnati College of Medicine
Co-authored papers 26
Co-authored papers 8
Co-authored papers 7
University of California
Co-authored papers 7
Northwestern University Feinberg School of Medicine
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Howard Hughes Medical Institute, Salk Institute for Biological Studies
Co-authored papers 4
University of California, USA Institute for Genomic Medicine
Co-authored papers 4
430482University of Tennessee Health Science Center
Co-authored papers 4
Co-authored papers 4
12220University of California San Diego
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Co-authored papers 3
Department of Medicine and Moores Cancer Center, University of California San Diego
Co-authored papers 3
Moores Cancer Center, university of california san diego
Co-authored papers 3
Massachusetts Institute of Technology
Co-authored papers 3
Cincinnati Children's Hospital Medical Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
University of California San Diego Moores Cancer Center
Co-authored papers 3
Institute for Genomic Medicine, University of California San Diego
Co-authored papers 3
Salk Institute of Biological Studies
Co-authored papers 3
University of California
Co-authored papers 3
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers 3
Center for Computational Biology & Bioinformatics (CCBB), University of California
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Salk Institute
Co-authored papers 2